25 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 25 of 25 clinical reviews.
MD/PharmD-level guide to diagnosing and correcting ezetimibe non-response: absorption variability, drug interactions, combination strategies, and escalation protocols backed by IMPROVE-IT and primary literature.
A clinician-reviewed guide to ezetimibe (Zetia) use after bariatric surgery, covering absorption changes, dosing, drug interactions, lipid outcomes, and post-bariatric cardiovascular risk management with primary-literature citations.
A clinician-level review of ezetimibe's effects on kidney function, CKD outcomes, and how IMPROVE-IT and post-hoc renal analyses inform prescribing decisions for patients with or at risk of chronic kidney disease.
A week-by-week breakdown of what happens in your first month on ezetimibe (Zetia), including LDL changes, side effects, timelines, and IMPROVE-IT trial data reviewed by the HealthRX medical team.
Does ezetimibe (Zetia) change appetite or food cravings? A physician-reviewed deep dive into the pharmacology, clinical trial data, and patient reports that answer this question.
A physician-reviewed guide to ezetimibe (Zetia) use in autoimmune disease, covering drug interactions, immune effects, cardiovascular benefit in lupus and RA, safety data from IMPROVE-IT, and practical dosing guidance.
Does ezetimibe (Zetia) affect bone mineral density or fracture risk? A physician-reviewed, primary-literature analysis of every major trial and mechanism study.
A physician-level review of the ezetimibe (Zetia) cancer risk signal, covering IMPROVE-IT data, post-marketing pharmacovigilance, NPC1L1 biology, and current ACC/AHA guideline recommendations.
A deep clinical review of ezetimibe's long-term cardiovascular impact, grounded in IMPROVE-IT, SHARP, and current ACC/AHA guidelines. Learn what the trial data show, who benefits most, and how to use ezetimibe in practice.
A clinician-level review of ezetimibe (Zetia) and cognition, covering IMPROVE-IT data, FDA post-market surveillance, proposed mechanisms, and how to counsel patients asking about memory or cognitive side effects.
A physician-reviewed comparison of compounded ezetimibe versus branded Zetia, covering bioequivalence evidence, regulatory status, IMPROVE-IT trial data, and how to choose the right formulation for LDL-C lowering.
A GRADE-graded review of ezetimibe (Zetia) evidence covering IMPROVE-IT, SHARP, and current ACC/AHA guideline recommendations, with dose, safety, and combination-therapy data for clinicians.
A clinical deep-dive into ezetimibe (Zetia) and its documented effects on hair and skin, including alopecia, rash, and urticaria reports from postmarketing data, IMPROVE-IT trial findings, and FDA labeling.
A clinician-level review of ezetimibe (Zetia) and liver function: ALT/AST elevations, hepatotoxicity risk, IMPROVE-IT data, and monitoring guidance for patients on statin combinations.
A physician-reviewed deep dive into ezetimibe (Zetia) and its effects on mental health, mood, depression, and cognitive function. Covers IMPROVE-IT data, pharmacology, and clinical guidance.
A clinical deep-dive into how ezetimibe (Zetia) is absorbed, metabolized, and excreted, and what the current evidence says about its effects on energy expenditure, thermogenesis, and metabolic rate.
A physician-level review of ezetimibe (Zetia) microdosing protocols, covering the pharmacology, IMPROVE-IT trial data, guideline recommendations, and whether sub-standard dosing has clinical support.
A physician-reviewed, evidence-based guide to using ezetimibe (Zetia) as a muscle-sparing lipid-lowering strategy, with primary-literature citations from IMPROVE-IT, ACC/AHA guidelines, and statin myopathy trials.
A comprehensive MD/PharmD-level guide to ezetimibe (Zetia) pre-operative management, hold timing, cardiovascular risk bridging, and resumption protocols, with primary-literature citations throughout.
Does stopping ezetimibe (Zetia) cause a rebound spike in LDL? Learn what the clinical evidence shows, how fast cholesterol rises, and what your doctor should do if you discontinue.
When and how to safely restart ezetimibe (Zetia) after acute illness, hospitalization, or surgery. Evidence-based guidance covering timing, monitoring, drug interactions, and special populations.
A physician-reviewed guide to ezetimibe (Zetia) seasonal use considerations, including how cold weather, diet shifts, adherence patterns, and drug interactions change across seasons. Includes IMPROVE-IT trial data, ACC/AHA guideline references, and clinical dosing guidance.
A physician-reviewed deep dive into ezetimibe (Zetia) and sexual function. We cover the mechanistic data, IMPROVE-IT trial findings, comparisons with statins, and what patients should expect based on current evidence.
A clinical deep-dive into whether ezetimibe (Zetia) affects sleep architecture, polysomnography findings, comparisons with statins, and what the current evidence says for patients on lipid-lowering therapy.
MD/PharmD-level guidance on ezetimibe (Zetia) dosing during travel, timezone crossings, missed-dose management, and drug interactions at altitude or in transit. Includes IMPROVE-IT trial context and ACC/AHA guideline references.